Brenda Larkin

2.9k total citations
9 papers, 521 citations indexed

About

Brenda Larkin is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Brenda Larkin has authored 9 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Brenda Larkin's work include Influenza Virus Research Studies (4 papers), Immunotherapy and Immune Responses (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Brenda Larkin is often cited by papers focused on Influenza Virus Research Studies (4 papers), Immunotherapy and Immune Responses (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Brenda Larkin collaborates with scholars based in United States. Brenda Larkin's co-authors include Barney S. Graham, Mary E. Enama, Richard A. Koup, Robert T. Bailer, Mario Roederer, Lewis McCurdy, Gary J. Nabel, Martha Nason, John R. Mascola and Ingelise J. Gordon and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Health Affairs.

In The Last Decade

Brenda Larkin

9 papers receiving 496 citations

Peers

Brenda Larkin

ID

EPIDE

VIROL

IMMUN

MB

Haili Tang United States

Scott Coley United States

Nina D. Russell United States

Jennifer Serwanga Uganda

Laura Novik United States

C. Jane Batten Australia

Michael Pfleiderer Germany

Lei Ba United States

Joan Fusco United States

Edward Nwanegbo United States

Haili Tang United States

Brenda Larkin

452 ×1.7

ID

134 ×0.7

EPIDE

447 ×2.4

VIROL

271 ×1.6

IMMUN

157 ×1.0

MB

Citations per year, relative to Brenda Larkin Brenda Larkin (= 1×) peers Haili Tang

Countries citing papers authored by Brenda Larkin

Since Specialization

Citations

This map shows the geographic impact of Brenda Larkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda Larkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda Larkin more than expected).

Fields of papers citing papers by Brenda Larkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda Larkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda Larkin. The network helps show where Brenda Larkin may publish in the future.

Co-authorship network of co-authors of Brenda Larkin

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda Larkin. A scholar is included among the top collaborators of Brenda Larkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda Larkin. Brenda Larkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Carter, Cristina, Katherine V. Houser, Galina V. Yamshchikov, et al.. (2019). Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial. PLoS ONE. 14(9). e0222178–e0222178. 16 indexed citations

2.

Houser, Katherine V., Galina V. Yamshchikov, Abbie R. Bellamy, et al.. (2018). DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial. PLoS ONE. 13(11). e0206837–e0206837. 23 indexed citations

3.

Ledgerwood, Julie E., Zonghui Hu, Pamela Costner, et al.. (2015). Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemporary Clinical Trials. 44. 112–118. 11 indexed citations

4.

Ledgerwood, Julie E., Abbie R. Bellamy, Robert B. Belshe, et al.. (2015). DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial. PLoS ONE. 10(5). e0125914–e0125914. 16 indexed citations

5.

Koup, Richard A., Mario Roederer, Laurie Lamoreaux, et al.. (2010). Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses. PLoS ONE. 5(2). e9015–e9015. 102 indexed citations

6.

Martin, Julie E., Mark K. Louder, Ingelise J. Gordon, et al.. (2008). A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial. Vaccine. 26(50). 6338–6343. 197 indexed citations

7.

Parrino, Janie, Lewis McCurdy, Brenda Larkin, et al.. (2006). Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naïve and vaccinia-immune individuals. Vaccine. 25(8). 1513–1525. 73 indexed citations

8.

Larkin, Brenda, et al.. (2005). An HIV Vaccine: As We Build It, Will They Come?. Health Affairs. 24(3). 643–651. 7 indexed citations

9.

McCurdy, Lewis, et al.. (2004). Modified Vaccinia Ankara: Potential as an Alternative Smallpox Vaccine. Clinical Infectious Diseases. 38(12). 1749–1753. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact